🇺🇸 BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ in United States

BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ (BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ in United States?

Marketing authorisation holder not available in our data.